Relation of bleeding patterns and factor VIII levels in children with hemophilia
Abstract
Background The high costs of factor VIII examination cause thedelay in the diagnosis of hemophilia A; consequently many pa-
tients do not receive adequate therapy which results in failure to
survive into adulthood or survive with creeple.
Objective To determine bleeding patterns of hemophilia A pa-
tients for the prediction of its classification.
Methods We perform retrospective analysis of hemophilia patients
at the Integrated Service Center of Hemophilia, Cipto Mangun-
kusumo Hospital, Jakarta.
Results Family history, age at the first bleeding, frequency of bleed-
ing, and factor VIII examination can significantly differentiate the
classification of hemophilia A (P=0.015; 0.014; <0.0001; and
<0.0001, respectively) while age groups, triggering trauma for the
first bleeding, type of the first bleeding, history of previous trauma,
the most frequent type of bleeding, age at diagnosis, and con-
sumption of cryoprecipitate cannot. (P=0.985; 0.475; 0.342; 0.318;
0.058; 0.477; and 0.547, respectively).
Conclusion Age at first bleeding, frequency of bleeding, and fam-
ily history can be used to predict classification of hemophilia A.
References
fluid phase. In: Nathan DG, Oski FA, editors. Hema-
tology of infancy and childhood. 4th ed. Philadelphia:
Saunders; 1993. p. 1605-50.
2. Corrigan JJ. Hemorrhagic disorder. In: Berhman RE,
Kleigman RM, Nelson WE, Vaughan III VC, editors.
Nelson textbook of pediatrics. 15th ed. Philadelphia:
Saunders; 1996. p. 1424-7.
3. Srivastava A. Delivery of hemophilia care in the de-
veloping world. Hemophilia 1998;4:33-40.
4. Isarangkura P. Hemophilia care in the developing
world: Benchmarking for excellence. Hemophilia
2002;8:205-10.
5. Ljung R, Vournas AS, Auberger KK. Treatment of chil-
dren with hemophilia in Europe: A survey of 20 cen-
tres in 16 countries. Hemophilia 2000;6:619-24.
6. Nillson IM. Hemophilia. Malmo: Pharmacia plasma
product;1994. p. 2-98.
7. Carvell JE, Duthie RB. Management of the hemo-
philic knee. In: Insall JN, editor. Surgery of the knee.
1st ed. New York: Churchill Livingstone;1998. p.
741-74.
8. Lusher JM, Warrier I. Hemophilia A. Hematol Oncol
Clin North Am 1992;6:1021-33.
9. Dimichele D, Neufeld EJ. Hemophilia: A new approach
to an old disease. Hematol Oncol Clin North Am
1998;12:1315-44.
10. On Wuzurike N, Warrier I, Lusher M. Types of bleed-
ing seen during the first 30 month of life with se-
vere hemophilia A and B. Hemophilia 1996;2:137-
40.
11. Jones P. Guideline for the development of national
programme for hemophilia. Newcastle: World Federa-
tions of hemophilia; 1996. p. 1-48.
12. Corrigan JJ. Coagulation disorders. In: Miller DR,
Baechner RL, editors. Blood disease of infancy and
childhood. 6th ed. Saint Louis: CV Mosby Company;
1990. p. 47-65.
13. Hillgartner MW, Mc Milan CW. Coagulation disor-
der. In: Miller DR, Pearson HA, Bachner RL, edi-
tors. Smith’s blood diseases of infancy and childhood.
4th ed. Saint Louis; 1978. p. 771-90.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-10-14
Published 2016-10-18